指南与共识血液净化与透析

氯喹、羟氯喹和奎宁中毒的体外治疗:EXTRIP工作组的系统综述与推荐

Extracorporeal Treatment for Chloroquine, Hydroxychloroquine, and Quinine Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.
指南 / 共识 · J Am Soc Nephrol · 2020-09-22

EXTRIP工作组系统综述了氯喹、羟氯喹和奎宁中毒时体外治疗的效果与指征。共纳入44项研究,三种药物均被归类为不可透析。数据不支持对严重氯喹或奎宁中毒患者在标准治疗外使用体外治疗(强推荐,证据质量极低)。羟氯喹证据不足,未形成正式推荐。

要点

  • 氯喹、羟氯喹和奎宁均被EXTRIP归类为不可透析,体外治疗不能显著清除。
  • 严重氯喹或奎宁中毒:不建议在标准治疗外使用体外治疗(强推荐,证据质量极低)。
  • 羟氯喹中毒的体外治疗证据不足,未形成正式推荐。

核心结论

  • EXTRIP工作组推荐反对使用体外方法增强严重氯喹或奎宁中毒患者的药物清除。
  • 羟氯喹虽被评估为不可透析,但临床证据不足以形成正式推荐。

研究设计与样本

  • EXTRIP工作组遵循已发表的EXTRIP方法进行系统综述,检索、筛选研究并提取数据。
  • 共纳入44项研究:3项体外研究、2项动物研究、28项患者报告或系列、11项药代动力学研究。

主要发现

  • 毒代或药代动力学分析涉及61例患者(氯喹13例、羟氯喹3例、奎宁45例)。
  • 临床数据分析涉及38例患者(氯喹中毒12例、羟氯喹中毒1例、奎宁中毒25例)。
  • 三种药物均被归类为不可透析(不能通过体外治疗实现有临床意义的清除)。

关键数值与推荐

  • 严重氯喹或奎宁中毒:不建议在标准治疗外使用体外治疗(强推荐,证据质量极低)。
  • 羟氯喹:评估为不可透析,但临床证据不足以支持正式推荐。

临床怎么用

  • 对严重氯喹或奎宁中毒患者,不应常规使用体外治疗来增强药物清除。
  • 羟氯喹中毒的体外治疗决策需个体化,缺乏正式推荐支持。

局限性

  • 总体证据质量极低,主要基于病例报告和药代动力学研究。
  • 羟氯喹的临床数据非常有限(仅1例患者),无法形成推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although chloroquine, hydroxychloroquine, and quinine are used for a range of medical conditions, recent research suggested a potential role in treating COVID-19. The resultant increase in prescribing was accompanied by an increase in adverse events, including severe toxicity and death. The Extracorporeal Treatments in Poisoning (EXTRIP) workgroup sought to determine the effect of and indications for extracorporeal treatments in cases of poisoning with these drugs. METHODS: We conducted systematic reviews of the literature, screened studies, extracted data, and summarized findings following published EXTRIP methods. RESULTS: A total of 44 studies (three in vitro studies, two animal studies, 28 patient reports or patient series, and 11 pharmacokinetic studies) met inclusion criteria regarding the effect of extracorporeal treatments. Toxicokinetic or pharmacokinetic analysis was available for 61 patients (13 chloroquine, three hydroxychloroquine, and 45 quinine). Clinical data were available for analysis from 38 patients, including 12 with chloroquine toxicity, one with hydroxychloroquine toxicity, and 25 with quinine toxicity. All three drugs were classified as non-dialyzable (not amenable to clinically significant removal by extracorporeal treatments). The available data do not support using extracorporeal treatments in addition to standard care for patients severely poisoned with either chloroquine or quinine (strong recommendation, very low quality of evidence). Although hydroxychloroquine was assessed as being non-dialyzable, the clinical evidence was not sufficient to support a formal recommendation regarding the use of extracorporeal treatments for this drug. CONCLUSIONS: On the basis of our systematic review and analysis, the EXTRIP workgroup recommends against using extracorporeal methods to enhance elimination of these drugs in patients with severe chloroquine or quinine poisoning.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Berling I, King JD, Shepherd G, et al. Extracorporeal Treatment for Chloroquine, Hydroxychloroquine, and Quinine Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup. J Am Soc Nephrol. 2020. PMID: 32963091. doi:10.1681/ASN.2020050564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。